# Safety and Efficacy Study of NGGT002 in PKU Adult Subjects

> **NCT06061614** · EARLY_PHASE1 · RECRUITING · sponsor: **The First Affiliated Hospital of Bengbu Medical University** · enrollment: 15 (estimated)

## Conditions studied

- Phenylketonurias

## Interventions

- **GENETIC:** NGGT002 Injection

## Key facts

- **NCT ID:** NCT06061614
- **Lead sponsor:** The First Affiliated Hospital of Bengbu Medical University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-03-30
- **Primary completion:** 2028-12-30
- **Final completion:** 2028-12-30
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2026-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06061614

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06061614, "Safety and Efficacy Study of NGGT002 in PKU Adult Subjects". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06061614. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*